Страна: Ирландия
Език: английски
Източник: HPRA (Health Products Regulatory Authority)
OXYBUTYNIN HYDROCHLORIDE
B & S Healthcare
G04BD04
OXYBUTYNIN HYDROCHLORIDE
5 Milligram
Tablets
Product subject to prescription which may be renewed (B)
Drugs for urinary frequency and incontinence
Authorised
2009-06-25
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Ditropan 5mg Tablets 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Each tablet contains 5mg oxybutynin hydrochloride as the active ingredient. Excipients include lactose. For a full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Tablet _Product imported from UK_: Pale blue circular tablet with a centre break-line on one side and marked ‘OXB5’ on the reverse. 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Urinary incontinence, urgency and frequency in the unstable bladder, whether due to neurogenic bladder disorders (detrusor hyperreflexia) in conditions such as multiple sclerosis and spina bifida, or to idiopathic detrusor instability (motor urge incontinence). It is also useful in the control of vesical hyperactivity seen after surgery of the bladder or prostate, or accompanying cystitis. PEADIATRIC POPULATION Oxybutnin hydrochloride is indicated in children over 5 years of age for: -Urinary incontinence, urgency and frequency in unstable bladder conditions due to idiopathic overactive bladder or neurogenic bladder disorders (detrusor overactivity). - Nocturnal enuresis associated with detrusor overactivity, in conjunction with non-drug therapy, when other treatment has failed. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION DOSAGE AND ADMINISTRATION _Adults: _The usual dose is 5mg two or three times a day. This may be increased to a maximum of 5 mg four times a day to obtain a clinical response provided that the side effects are tolerated. _Elderly: _The elimination half-life is increased in the elderly, therefore, a dose of 2.5mg twice a day, particularly if the patient is frail, is likely to be adequate. This dose may be titrated upwards to 5mg two times a day to obtain a clinical response provide Прочетете целия документ